18-methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17b-carbolactones, pharmaceutical preparations comprising said compounds and use thereof in the treatment of endometriosis
AssigneesBayer Pharma Aktiengesellschaft, Bayer Intellectual Property GmbH
InventorsJan Hübner, Rolf Bohlmann, Isabella Gashaw, Oliver Martin Fischer, Joachim Kuhnke, Norbert Gallus, Reinhard Nubbemeyer, Ildiko Terebesi
Life of this patent
Estimating the term…
Abstract
The present invention relates to 18-methyl-6,7-methylene-17-pregn-4-ene-21,17β-carbolactones of general formula I wherein the 6,7-methylene group can be in α- or β position, pharmaceutical preparations containing at least one isomer of formula I and use thereof in the treatment of endometriosis.
Claims7
18-Methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17β-carbolactones of formula I, in which the 6,7-methylene group can be in the α or β position
18-Methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17β-carbolactone for use in the treatment of endometriosis.
18-Methyl-6β,7β-methylene-3-oxo-17-pregn-4-ene-21,17β-carbolactone for use in the treatment of endometriosis.
Dependencies are inferred from the claim text.